The Stock

Discussion in 'Wright Medical' started by anonymous, Mar 9, 2017 at 7:34 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Short term, maybe mid-20s if we post a decent quarter and right the ship with solid growth.

    Long term, it’s a dog. With our operations and top level salaries, we will never be profitable and rely on debt. This is fine in high growth but now that our product pipeline has dried up we are in big trouble for 2018. I would be VERY cautious with even holding your WMGI.
     

  2. anonymous

    anonymous Guest

    Thank you for the insight. It is nice to read a post that is not absurd nor idiotic.
     
  3. anonymous

    anonymous Guest

    Along with the stock’s decline, notice the company has also lost $1 Billion in market cap in the last year. And while the stock price may continue to fluctuate, the future is not rosy. If you are a shareholder, you should be very concerned about the performance of the Lower Extremity Business Unit. The numbers from Q4 ‘17 have yet to be released and the January numbers are worse than a year ago which can only mean another disastrous Q1 earnings call to look forward to.

    The Board meeting this week will be interesting.
     
  4. anonymous

    anonymous Guest

    They need to sell

     
  5. anonymous

    anonymous Guest

    We are about to see sub $20 in stock
    price. Wonder when the board tires of the Bobs act and makes a change.
     
  6. anonymous

    anonymous Guest

    Yes, and the board should note that the Bobs are responsible for the LE side, while coasting off the success of UE (which they had nothing to do with).
     
  7. anonymous

    anonymous Guest

    Just think how much better it will be when "Hubs" are completely rolled out for UE.
     
  8. anonymous

    anonymous Guest

    Will the stock ever see $30 again?
     
  9. anonymous

    anonymous Guest

    Stock will go up.